WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Natco Pharma Limited logo

Natco Pharma Limited

DecreasedSAST
NATCOPHARMPharmaceuticalsMarket Cap₹16K Cr
Stake
0.13% → 0.09%
Deal value
₹11.63 Cr
Shares
1.15 L
Trade date
9 Mar 2026
Since alert−18.8%₹1,002.70 → ₹814.30
Nifty 50+7.4%
SA
SANJAY NANNAPANENI and SATYA VANI NANNAPANENI
Promoter
The move

Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.

About Natco Pharma Limited
+ FollowVisit stock

A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.

Get the next move the moment it happens.
Follow the investors and Natco Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Natco Pharma Limited shareholdersAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Natco Pharma Limited
More moves in Natco Pharma Limited
5newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Xxxxx Xxxxxxxxxxxxxx xxxxxx xxx xxxx
Unlock all 5 moves
See all moves